Duits-Oostenrijks-Zwiterse Homocysteine Liga
NB - de website is in het Duits maar rechts bovenin kan je het in de Engelstalige versie lezen.
AANVULLING: ONDER INTERACTIONS
STAAT DIT GEDEELTE - MET LINKS OM GEHEEL TE LEZEN - OVER DE SCHILDKLIER:
Thyroid gland
Most patients with an overactive thyroid (hyperthyreosis) have lower homocysteine levels whilst the concentrations of homocysteine found in hypothyroid patients are clearly more elevated than in healthy persons. This may be due to the higher folic acid levels that have repeatedly been found in persons with an overactive thyroid or due to the lower folate levels seen in hypothyroid patients. Cobalamin concentrations do not appear to change. In addition, thyroid function affects the activity of MTHFR: its activity increases during hyperthyreosis and is reduced in persons with underactive thyroid. Hypothyreosis can also disturb the conversion of riboflavin to FAD, which can equally affect the activity of MTHFR.
Even other enzymes such as CBS or MS may be affected. Furthermore, a change of kidney function may have an effect; for example, a lower glomerular filtration rate (GFR) is found in patients with hypothyreosis (with increased serum creatinine) whereas in people with an overactive thyroid, creatinine levels are frequently decreased and GFR is mostly elevated . During the therapy of thyroid dysfunction, homocysteine concentrations change, in most cases, in line with the creatinine values (however not in line with the folate levels), which suggests a renal mechanism. The thyroid hormone thyroxine (T4) is an independent determinant for plasma homocysteine concentrations. A therapy based on L-thyroxine to treat patients with hypothyroidism leads to a 40–50% reduction in plasma homocysteine after establishing an euthyroid metabolism. However, in all therapy studies, the folate and creatinine values provide no more than a partial explanation of the homocysteine changes.
In any case, elevated homocysteine levels can be a sign of hypothyroidism and should be taken as an opportunity to determine TSH.
Literature (selection):
Morris MS, et al. Hyperhomocysteinemia and Hypercholesterolemia Associated With Hypothyroidism in the Third NHANES. Atherosclerosis 2001;155:195–200 PubMed
Bičiková M, et al. Effect of Treatment of Hypothyroidism on the Plasma Concentrations of Neuroactive Steroids and Homocysteine. Clin Chem Lab Med 2001;39:753–7 PubMed
Diekman MJ, et al. Determinants of Changes in Plasma Homocysteine in Hyperthyroidism and Hypothyroidism. Clin Endocrinol 2001;54:197–204 PubMed
Nedrebø BG, et al. Plasma Levels of Homocysteine are Changed During Treatment of Hyper- and Hypothyroidism. Abstract. 3rd International Conference. Sorrent (2001)
Lien EA, et al. Plasma Total Homocysteine Levels During Short-Term Iatrogenic Hypothyroidism. J. Clin Endocrinol Metab 2000;85:1049–53 PubMed
Hussein WI, et al. Normalization of Hyperhomocysteinemia With L-Thyroxine in Hypothyroidism. Ann Intern Med 1999;131:348–51 PubMed
Catargi B, et al. Homocysteine, Hypothyroidism, and Effect of Thyroid Hormone Replacement. Thyroid 1999;9:1163–6 PubMed
Nedrebø BG, et al. Plasma Total Homocysteine Levels in Hyperthyoid and Hypothyroid Patients. Metabolism 1998;47:89–93 PubMed
Nair CP, et al. Folate-Mediated Incorporation of Ring-2-Carbon of Histidine Into Nucleic Acids: Influence of Thyroid Hormones. Metabolism 1994;43:1575–8 PubMed
Ford HC, et al. Serum and Red Cell Folate and Serum Vitamin B12 Levels in Hyperthyroidism. Am J Haematol 1992;31:233–6 PubMed
Shirota T, et al. Alteration of Renal Function in Hyperthyroidism: Increased Tubular Secretion of Creatinine and Decreased tubular Delivery of Chloride. Metabolism 1992;41:402–5 PubMed
Cimino JA, et al. Riboflavin Metabolism in the Hypothyroid Human Adult. Proc Soc Exp Biol Med 1987;184:151–3 PubMed
Discala VA, et al. Effects of Myxedema on the Renal Diluting and Concentration Mechanisms. Am J Med 1971;50:325–35
Vertaald met behulp van Google-vertalingDe meeste patiënten met een overactieve schildklier (hyperthyreosis) hebben een lagere niveaus homocysteïne, terwijl de concentratie van homocysteïne in hypothyroid patiënten zijn duidelijk meer verhoogd dan bij gezonde personen.
Dit wordt mogelijk veroorzaakt door de hogere foliumzuur niveaus die herhaaldelijk hebben gevonden bij personen met een overactieve schildklier of als gevolg van de lagere niveaus folaat gezien in hypothyroid patiënten.
Cobalamin concentraties lijken niet te veranderen. Daarnaast dient de schildklierfunctie van invloed op de activiteit van MTHFR: haar activiteit verhoogt tijdens hyperthyreosis en wordt verlaagd bij personen met underactive schildklier. Hypothyreosis kan ook verstoring van de conversie van riboflavine tot FAD, die eveneens van invloed op de activiteit van MTHFR.
Ook andere enzymen zoals het CBS of MS kunnen worden beïnvloed. Bovendien is een verandering van de nierfunctie kan gevolgen hebben, bijvoorbeeld een lagere glomerulaire filtratiesnelheid (GFR) is geconstateerd bij patiënten met hypothyreosis (met een verhoogd serumcreatinine), terwijl bij mensen met een overactieve schildklier, creatinine levels zijn vaak verminderd en GFR is meestal verhoogd. Tijdens de therapie van schildkliercarcinoom disfunctie, homocysteïne concentraties veranderen, in de meeste gevallen, in lijn met de creatinine-waarden (echter niet in overeenstemming met de folaat-niveau), die suggereert dat er een nier-mechanisme.
Het schildklierhormoon thyroxine (T4) is een onafhankelijke determinant voor plasma homocysteine concentraties. Een therapie gebaseerd op de L-thyroxine voor de behandeling van patiënten met hypothyreoïdie leidt tot een 40-50% reductie in plasma homocysteine na de oprichting van een euthyroid metabolisme. Echter, in alle therapie studies, de folaat en creatinine waarden zorgen voor niet meer dan een gedeeltelijke verklaring van het homocysteïne veranderingen.
In ieder geval, verhoogde homocysteïne niveaus kunnen een teken zijn van hypothyreoïdie en moet als een kans om te bepalen TSH.
The DACH-Liga Homocystein e.V. is introducing itself
The DACH-Liga Homocystein e.V. was set up in 2003 and April of that year saw its introduction to the general public during the ‘3rd Conference on Hyperhomocysteinemia’ in Saarbrücken/Germany. The first guidelines and recommendations by the DACH-Liga Homocystein were presented in the form of a consensus paper.
The society is an interdisciplinary association of established scientists from the DACH countries (Germany, Austria and Switzerland) who are involved in research in the field of homocysteine, relevant vitamins and associated illnesses in the wider sense.
The Board of the DACH-Liga Homocystein consists of the following persons:
Prof. Dr. O. Stanger - Chairman
Prof. Dr. K. Pietrzik – Deputy Chairman
Prof. Dr. B. Fowler - Treasurer
PD. Dr. S. Lorenzl - Secretary
The society’s purpose is the promotion of research and information on homocysteine, in particular with regard to diagnosis, therapy and prevention. To carry out this task, the society is involved
in the issuing of guidelines and recommendations
the organisation of scientific conferences and events
the planning and carrying out as well as the sponsoring of research projects
the networking with other scientific societies that pursue similar goals
the publishing and providing of information covering the society’s fields of interest and,
at times, the setting up of working parties.
Menu:Home
* DACH-Liga
* Specialist info
* Specialist Reading
* Events
* Lectures (german)
* Ordering
* Links
* In a nutshell
* Contact
Met deze onderwerpen die daarna weer verder uitgelicht zijn:History
* Homocysteine
* Folic acid
* Vitamin-B12
* Vitamin-B6
* Genetics
* Laboratory and test
* Interactions
* Acronyms
bijvoorbeeld:
Homocysteine:
*The concept of risk factors
* Risk factor homocysteine
* Metabolism
* Forms of homocysteine
* Enzymes involved in the metabolism of homocysteine/methionine
* B-Vitamins as co-factors of enzymes
Vitamine B12:
* vitamin-B12 (Cobalamin)
* metabolism
* vitamin-B12 deficiency
* vitamin-B12
* geriatrics
* Anaemia
* Diagnosing deficiency
* Safe useSpecialist societies
* American Academy of Family Practitioners
* American College of Cardiology
* American Heart Organisation
* American Society for Nutrition
* Working Party for Folic Acid & Health (D)
* British Nutrition Foundation
* German Society for Nutrition
* European Society of Cardiology
* FASEB
* Federation of European Nutrition Societies
* Nutrition Forum (Ö)
* Society for Applied Vitamin Research (D) ( http://www.vitaminforschung.org/ )
* Nutrition Society (UK)
* Society for Applied Vitamin Research (D) ( http://www.oege.at/ )
* Austrian Green Cross for Health
* Swiss Society for NutritionLectures (german)
Wozu braucht der Mensch eigentlich Folsäure und Vitamin B12? Dimension des Problems - O. Stanger
Was wir wirklich essen. Quellen für Folsäure und Vitamin B12 - M. Benedikt
Ergebnisse einer Untersuchung in Salzburg und Tirol. Zielgruppen für Vitaminmangel - O. Stanger
Folsäure und Neuralrohrdefekte in Österreich - O. Stanger
Krankheiten bei Folsäure- und Vitamin B12-Mangel - Depression, M. Alzheimer, Demenz, M. Parkinson - S. Lorenzl
Herz-Kreislauf-Erkrankungen - O. Stanger
Folsäure in Verbindung mit Tumorerkrankungen - B. Fowler
Die Bedeutung von Folsäure und Vitamin B12 in der Augenheilkunde - M. Weger
Erhöhtes Homocystein - Ein neuer Risikofaktor der Osteoporose - M. Herrmann
Ernährung, Tabletten oder Anreicherung? - O. Stanger
Vermeiden von Vitaminverlusten in der Küche - M. Benedikt
Prävention mit Folsäure und Vitamin B12 bei Depression, M. Alzheimer, M. Parkinson - S. Lorenzl
Dimensionen eines Problems - O. Stanger
Der Österr. Ernährungsbericht. Ursachen des Folsäure- und Vitamin-B12-Mangels - M. Benedikt
Ergebnisse einer Untersuchung in Salzburg und Tirol. Zielgruppen für Vitaminmangel - O. Stanger
Homocystein: Stellenwert in der Diagnostik - J. Geisel
Präanalytik, rationelle Diagnostik in der Praxis, MTHFR, Therapieversager - B. Fowler
Wechselwirkungen mit Medikamenten. Drug monitoring - O. Stanger
VISP, NORVIT und andere Missverständnisse - O. Stanger
Krankheiten bei Folsäure- und Vitamin B12-Mangel - Depression, M. Alzheimer, Demenz, M. Parkinson - S. Lorenzl
Die Bedeutung von Folsäure und Vitamin B12 in der Augenheilkunde - M. Weger
Herz-Kreislauf-Erkrankungen - O. Stanger
Folsäure in Verbindung mit Tumorerkrankungen - B. Fowler
Prävention und klinische Erfolge mit Folsäure und B-Vitaminen - Empfehlungen zum praktischen Umgang bei kardiovaskulären Erkrankungen - J. Geisel
Die Welt, in der wir leben. Grenzen und Überschreitungen - Franz Eckert
Ernährungsgewohnheiten, Denk- und Auswahlschablonen - Ingrid Kiefer
Bio vs. konventionell: gibt es Be- und Nachweise? - Ingrid Kiefer
Lebensmittel mit Gesundheitsnutzen (Functional Food) - Maria Benedikt
Chem. Gifte in Lebensmittelverpackungen - Rudolf Franz
Luft und Sauerstoff - Eine kurze Geschichte der Evolution - Olaf Stanger
Radikale und Radikalfänger - Willi Wonisch
Folsäure als Antioxidans - Olaf Stanger
Chem. Gifte in Lebensmittelverpackungen - Rudolf Franz
Luft und Sauerstoff - Eine kurze Geschichte der Evolution - Olaf Stanger
Radikale und Radikalfänger - Willi Wonisch
ALLE artikelen hieronder zijn geheel te lezen via PDF bestand -
BEHALVE:
Total homocysteine, B-vitamins and genetic polymorphisms in patients with classical phenylketonuria. Mol Genet Metab 2008 PDFPublications
Here you will find selected publications by the members of the DACH-Liga-Homocystein.
* Gene identification for the cblD defect of vitamin B12 metabolism. N Engl J Med 2008 PDF
* Methylmalonic aciduria articles. J Inherit Metab Dis 2008;31:4. PDF
* Total homocysteine, B-vitamins and genetic polymorphisms in patients with classical phenylketonuria. Mol Genet Metab 2008 PDF
* Cardiovascular fitness is negatively associated with homocysteine levels in female adolescents. Arch Pediatr Adolesc Med 2007 PDF
* Effect of folate supplementation on N-terminal pro-brain natriuretic peptide. Int J Cardiol 2007;118:267-9. PDF
* Increased asymmetric dimethylarginine concentrations in stimulated peripheral blood mononuclear cells. Scand J Immunol 2007 PDF
* Hyperhomocysteinaemia and compound heterozygosity for the common variant c.677C>T and a MTHFR gene mutation. J Inherit Metab Dis 2007 PDF
*Transient global amnesia-like episode in a patient with severe hyperhomocysteinemia. Eur J Neurol 2007 PDF
* Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res 2007 PDF
* Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis 2007 PDF
* Angiotensin-converting enzyme insertion/deletion polymorphism and retinal artery occlusion. Acta Ophthalmol Scand 2006 PDF
* Methylenetetrahydrofolatereductase (MTHFR) 677C>T polymorphism and open angle glaucoma. Mol Vis 2006 PDF
* The methionine synthase polymorphism c.2756A>G alters susceptibility to glioblastoma multiforme. Cancer Epidemiol Biomarkers Prev 2006 PDF
* Prenatal and postnatal treatment in cobalamin C defect. J Pediatr 2005 PDF
* Homocysteine and carotid intima-media thickness in a german population: lack of clinical relevance. Stroke 2006 PDF
* Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. Ophthalmology 2005 PDF
* The first case of 3-methylcrotonyl-CoA carboxylase (MCC) deficiency responsive to biotin. Neuropediatrics 2006 PDF
* Methionine adenosyltransferase (MAT) I/III deficiency with concurrent hyperhomocysteinaemia: two novel cases. J Inherit Metab Dis 2005 PDF
* Levodopa intake increases plasma levels of S-adenosylmethionine in treated patients with Parkinson disease. Clin Neuropharmacol. 2005 PDF
* Methylenetetrahydrofolate reductase in Parkinson's disease. Ann Neurol 2005 PDF
* Homocysteine, folate, and cobalamin, and their relation to genetic polymorphisms, lifestyle and BMI in healthy children and adolescents. Pediatr Res 2006 PDF
* Prenatal and postnatal treatment in cobalamin C defect. J Pediatr 2005 PDF
* Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia 2005 PDF
* Clinically and MRI documented funicular myelosis in a patient with metabolical vitamin B12 deficiency but normal vitamin B12 serum level. J Neurol 2003 PDF
* Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology 2002 PDF
* Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002 PDF
* Homocystein über den rationellen klinischen Umgang mit Homocystein, Folsäure und B-Vitaminen bei kardiovaskulären und thrombotischen Erkrankungen PDF
* Folate-Therapy and In-Stent Restenose, N Engl J Med. 2004 PDF
* Homocystein - Grundlagen, Klinik, Therapie und Prävention ein Buch von Prof. Dr. Olaf Stanger PDF
* Physiology of Folic Acid in Health and Disease. Curr Drug Metab 2002 PDF
* Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases - Z Kardiol 2004 PDF
* Effects of Folate Treatment and Homocysteine Lowering on Resistance Vessel Reactivity in Atherosclerotic SubjectJ Pharmacol Exp Ther 2002 PDF
* Interactions of Homocysteine, Nitric Oxide, Folate and Radicals in the Progressively Damaged Endothelium - Clin Chem Lab Med 2003 PDF
* Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease - Atherosclerosis 2002 PDF
* Vascular Dysfunction in Hyperhomocyst(e)inemia. Implications for Atherothrombotic Disease - Clin Chem Lab Med 2001 PDF
* The cblD Defect Causes Either Isolated or Combined Deficiency of Methylcobalamin and Adenosylcobalamin Synthesis. J Biol Chem 2004 PDF
* 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Assay in the Forward Direction: Residual Activity in MTHFR Deficiency - Clin Chem 2002 PDF
* cblE Type of Homocystinuria Due To Methionine Synthase Reductase Deficiency: Functional Correction by Minigene Expression. Hum Mutat 2005 PDF
* Effect of 5-MTHF and folic acid on plasma homocysteine in healthy subjects with or without the 677C->T polymorphism of MTHFR. Eur J Clin Invest 2002 PDF
* The folate cycle and disease in humans - Kidney International, 2001 PDF
* Disturbed ratio of erythrocyte and plasma SAM:SAH in peripheral arterial occlusive disease - Atherosclerosis 2001 PDF
* Vitamin B-12 status, particularly HoloTC II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr 2003 PDF
* Response of Homocysteine, Cystathionine, and Methylmalonic Acid to Vitamin Treatment in Dialysis Patients. Clin Chem 2005 PDF
* Total Homocysteine, Vitamin B12, and Total Antioxidant Status in Vegetarians. Clin Chem 2001 PDF
* Disturbed Homocysteine and Methionine Cycle Intermediates SAH and SAM are Related to Degree of Renal Insufficiency in Type 2 Diabetes. Clin Chem 2005 PDF
* Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects. Eur J Clin Invest 2000 PDF
* The impact of vegetarianism on some haematological parameters - Eur J Haematol 2002 PDF
* Post–Methionine-Load Hyperhomocysteinemia and Increased Lp(a) Are Associated With Renal Metabolic Dysfunction. 2002 PDF
* Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy Clin Chem Lab Med 2005 PDF
ER IS ENORM VEEL INFO TE VINDEN.
In het Duits:
http://www.dach-liga-homocystein.org/
In het Engels:
http://www.dach-liga-homocystein.org/EN/index.htm
